Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Crystalglobulinemia syndrome due to monoclonal gammopathy of renal significance.

Tsuji T, Itoh Y, Nakamura T, Toyozumi Y, Arima N, Tsuda H.

QJM. 2015 May;108(5):417-8. doi: 10.1093/qjmed/hcu114. No abstract available.

PMID:
24917131
2.

Diagnosis of monoclonal gammopathy of renal significance.

Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, Picken MM, Herrera GA, Kastritis E, Merlini G, Roussel M, Fervenza FC, Dispenzieri A, Kyle RA, Nasr SH; International Kidney and Monoclonal Gammopathy Research Group..

Kidney Int. 2015 Apr;87(4):698-711. doi: 10.1038/ki.2014.408. Review.

PMID:
25607108
3.

Monoclonal gammopathy of renal significance: systemic involvement by benign condition.

L'Imperio V, Fabbrini P, Ferrario F, Pieruzzi F, Tosoni A, Brivio R, Maria Pogliani E, Pagni F.

Kidney Int. 2015 Jul;88(1):200-2. doi: 10.1038/ki.2015.134. No abstract available.

PMID:
26126102
4.

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Kristinsson SY, Björkholm M, Andersson TM, Eloranta S, Dickman PW, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O.

Haematologica. 2009 Dec;94(12):1714-20. doi: 10.3324/haematol.2009.010066.

5.

Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.

Weiss BM, Minter A, Abadie J, Howard R, Ascencao J, Schechter GP, Kuehl M, Landgren O.

Am J Hematol. 2011 Jun;86(6):475-8. doi: 10.1002/ajh.22025.

6.

Monoclonal gammopathy of undetermined significance.

Anguille S, Bryant C.

CMAJ. 2013 Oct 15;185(15):1345. doi: 10.1503/cmaj.122090. Review. No abstract available.

7.

Monoclonal gammopathy of renal significance with light-chain deposition disease diagnosed postrenal transplant: a diagnostic and therapeutic challenge.

Nambirajan A, Bhowmik D, Singh G, Agarwal SK, Dinda AK.

Transpl Int. 2015 Mar;28(3):375-9. doi: 10.1111/tri.12497.

8.

Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma.

Espiño M, Medina S, Blanchard MJ, Villar LM.

Br J Haematol. 2014 Mar;164(5):752-5. doi: 10.1111/bjh.12679. No abstract available.

PMID:
24261626
9.

Monoclonal gammopathy of undetermined significance: an update for nephrologists.

Parry HM, Pratt G, Hutchison CA.

Adv Chronic Kidney Dis. 2012 Sep;19(5):291-6. doi: 10.1053/j.ackd.2012.07.006. Review.

PMID:
22920639
10.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.

Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Review.

PMID:
25212882
11.

Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.

Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA; International Kidney and Monoclonal Gammopathy Research Group..

Blood. 2012 Nov 22;120(22):4292-5. doi: 10.1182/blood-2012-07-445304. Review.

12.

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, Hajek R, Kleber M, Ludwig H, Morgan G, Musto P, Plesner T, Sezer O, Terpos E, Waage A, Zweegman S, Einsele H, Sonneveld P, Lokhorst HM; European Myeloma Network..

Haematologica. 2014 Jun;99(6):984-96. doi: 10.3324/haematol.2013.100552. Review.

13.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Kyle RA, Rajkumar SV.

Hematol Oncol Clin North Am. 2007 Dec;21(6):1093-113, ix.

PMID:
17996590
14.

[Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance. A new observation and literature review].

Khammassi N, Riahi L, Mohsen D, Tougourti MN, Hamza M.

Tunis Med. 2010 Apr;88(4):296. Review. French. No abstract available.

15.

Prognostic factors in monoclonal gammopathy of undetermined significance.

Sackmann F, Pavlovsky MA, Corrado C, Pizzolato M, Alejandre M, Pavlovsky S.

Haematologica. 2008 Jan;93(1):153-4. doi: 10.3324/haematol.11744.

16.

The Authors Reply.

Bridoux F, Leung N, Fermand JP, Touchard G, Nasr SH.

Kidney Int. 2015 Jul;88(1):202. doi: 10.1038/ki.2015.136. No abstract available.

PMID:
26126104
17.
18.

Usefulness of the kappa/lambda ratio for detecting a new monoclonal component in a patient with a monoclonal gammopathy.

Myara I, Asso M, Tenenhaus D, Moatti N.

Clin Chim Acta. 1994 Nov;231(1):115-6. No abstract available.

PMID:
7704944
19.

Ocular copper deposition associated with monoclonal gammopathy of undetermined significance: case report.

Tzelikis PF, Laibson PR, Ribeiro MP, Rapuano CJ, Hammersmith KM, Cohen EJ.

Arq Bras Oftalmol. 2005 Jul-Aug;68(4):539-41.

20.

Clinical practice. Monoclonal gammopathy of undetermined significance.

Bladé J.

N Engl J Med. 2006 Dec 28;355(26):2765-70. Review. No abstract available.

PMID:
17192542
Items per page

Supplemental Content

Support Center